NCT01621152

Brief Summary

Introduction: Acute kidney injury (AKI) increases mortality, hospital cost, and rate of progression toward end stage kidney disease 1-4. Early diagnosis and management of AKI is known to improve the above mentioned outcomes. Hypothesis: the investigators will design and validate an electronic surveillance tool to screen all the ICU admissions for the earlier, more efficient diagnosis of AKI and as a result improve the outcome of AKI in ICU patients. Methods: the investigators plan to use the patient database, and AKIN (AKI network) definition to design an electronic alert system to allow clinicians discover patients who develop AKI. Then a randomized clinical trial will be conducted to compare earlier intervention (based on Kidney Disease: Improving Global Outcomes \[KDIGO\] guidelines) initiated by AKI sniffer alert to the conventional management provided by primary physician in ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,266

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2012

Completed
18 days until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 18, 2012

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 19, 2021

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

9.4 years

First QC Date

May 14, 2012

Last Update Submit

June 21, 2022

Conditions

Keywords

Acute renal failureacute kidney injuryelectronic surveillanceAKIsnifferAKINimprovement in the process of care and outcomes

Outcome Measures

Primary Outcomes (1)

  • Change in acute kidney injury as measured by the Acute Kidney Injury Network Staging System

    The Acute Kidney Injury Network staging system is based on data indicating that a small change in serum creatinine influences outcome. Increases in serum creatinine or decreased urine output indicate greater kidney injury, with the stage ranging from 1 to 3. The higher the number, the greater the kidney injury.

    baseline, 4 weeks

Study Arms (2)

Conventional management arm

OTHER

Patients with AKI receive standard of care in the conventional manner by the primary clinicians

Other: Conventional management arm

AKI sniffer instigated AKI management

ACTIVE COMPARATOR

primary clinicians for the AKI patients in this arm receive a verbal alert and reminder of KDIGO guidelines.

Other: AKI sniffer instigated AKI management

Interventions

Based on KDIGO guidelines and as per primary physician in the ICU

Conventional management arm

After identification of patients with AKI by the sniffer, primary physicians will be notified about the development of the syndrome and will be given a copy of the KDIGO guidelines for management of AKI.

AKI sniffer instigated AKI management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients who are admitted in adult ICUs in Mayo Clinic Rochester
  • Foley catheter for hourly UOP measurement

You may not qualify if:

  • Prisoners
  • Patients less than 18 years old.
  • Lack of research authorization (in control group)
  • ESRD on dialysis or s/p kidney transplantation
  • Known AKI before admission to ICU
  • Moribund patients
  • Prevalent AKI admission in ICU (patients who have diagnosis of AKI documented in their medical records prior to ICU admission)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Kianoush Kashani, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant in Nephrology and Critical Care Medicine

Study Record Dates

First Submitted

May 14, 2012

First Posted

June 18, 2012

Study Start

June 1, 2012

Primary Completion

October 19, 2021

Study Completion

October 19, 2021

Last Updated

June 22, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

We plan to share IPD after initiation of patient recruitment.

Locations